New drug XFB19 takes first step: safety check in healthy people
NCT ID NCT05361733
First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 19 times
Summary
This early-stage study is the first time the experimental drug XFB19 is being tested in humans. The main goal is to check its safety in 40 healthy adults aged 18 to 55. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and how the drug moves through the body. This study does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCUS OF THE STUDY: SAFETY OF XFB19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AMR Clinical
RECRUITINGKnoxville, Tennessee, 37920, United States
Conditions
Explore the condition pages connected to this study.